Ovid Therapeutics Appoints Dr. Jerome B. Zeldis To Its Scientific Advisory Board

NEW YORK--(BUSINESS WIRE)--Ovid Therapeutics Inc. (Ovid), a privately held biopharmaceutical company focused on developing therapies for rare and orphan diseases of the brain, announced today the appointment to its Scientific Advisory Board (SAB) of Jerome B. Zeldis, M.D., Ph.D., Chief Executive Officer of Celgene Global Health and Chief Medical Officer of Celgene Corporation.

Help employers find you! Check out all the jobs and post your resume.